Showing results (231-240 of 522) with videos related to

Sort By:
Pageof 53
British Journal of Pharmacology|April 20, 2010
LASSBio-881: an N-acylhydrazone transient receptor potential vanilloid subfamily type 1 antagonist orally effective against the hypernociception induced by capsaicin or partial sciatic ligationJ L M Tributino, M L H Santos, C M Mesquita, et al.
Investigational New Drugs|May 17, 2024
In vitro results with minimal blood toxicity of a combretastatin A4 analogueCamila Chagas, Jaqueline Vital Mansano, Emerson Barbosa da Silva, et al.
Pharmacological Reports : PR|October 18, 2011
Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammationAline C Brando Lima, Alexandre L Machado, Patrícia Simon, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 21, 2014
Toxicological in vitro and subchronic evaluation of LASSBio-596G L Araujo, A E D Vieira, E J Barreiro, et al.
ACS Omega|May 12, 2025
Exploring the Conformational Effects of <i>N</i>- and <i>C</i>-Methylation of <i>N</i>-AcylhydrazonesLucas Silva Franco, Marina Amaral Alves, Carlos Mauricio R Sant'Anna, et al.
European Journal of Pharmacology|September 21, 2019
LASSBio-596 protects gastric mucosa against the development of ethanol-induced gastric lesions in miceCarlos Eduardo S Monteiro, Johnatan Alisson Oliveira Sousa, Lídia Moreira Lima, et al.
European Journal of Medicinal Chemistry|January 29, 2013
Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compoundTatiana F Gomes, Thais E T Pompeu, Daniel A Rodrigues, et al.
Pharmaceutics|April 28, 2023
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer AgentCelina de Jesus Guimarães, Teiliane Rodrigues Carneiro, Marisa Jadna Silva Frederico, et al.
Toxicon : Official Journal of the International Society on Toxinology|February 19, 2018
Oxidative imbalance in mice intoxicated by microcystin-LR can be minimizedNatália V Casquilho, Maria Diana Moreira-Gomes, Clarissa B Magalhães, et al.
British Journal of Pharmacology|March 28, 2013
Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in ratsAllan K N Alencar, Sharlene L Pereira, Tadeu L Montagnoli, et al.
Pageof 53